Colon Targeted Rifaximin Nanosuspension for the Treatment of Inflammatory Bowel Disease (IBD)

By  

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 15, Iss. 2, 2016-12 ,pp. : 101-117

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Treatment Options for Inflammatory Bowel Disease: Targeting α4 Integrin

By Lanzarotto Francesco   Carpani Marta   Chaudhary Rakesh   Ghosh Subrata  

Drugs, Vol. 66, Iss. 9, 2006-01 ,pp. : 1179-1189

Adis International

Access to resources Recommend Favorite

Infliximab use appears to increase the risk of heart disorders, including arrhythmias, in children with inflammatory bowel disease (IBD)

By  

Reactions Weekly, Vol. 1, Iss. 1117, 2006-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Infliximab use appears to increase the risk of heart disorders, including arrhythmias, in children with inflammatory bowel disease (IBD)

By  

Inpharma, Vol. 1, Iss. 1553, 2006-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

Is There Still a Room for Azathioprine Monotherapy in Inflammatory Bowel Disease?

By  

Current Drug Targets, Vol. 14, Iss. 12, 2013-11 ,pp. : 1471-1479

Bentham Science Publishers

Access to resources Recommend Favorite